Iattoni, Elena
 Distribuzione geografica
Continente #
NA - Nord America 576
EU - Europa 307
AS - Asia 91
Continente sconosciuto - Info sul continente non disponibili 2
Totale 976
Nazione #
US - Stati Uniti d'America 562
GB - Regno Unito 113
SE - Svezia 55
IE - Irlanda 46
CN - Cina 34
IT - Italia 29
DE - Germania 23
HK - Hong Kong 23
UA - Ucraina 17
CA - Canada 13
SG - Singapore 12
FR - Francia 9
BG - Bulgaria 6
TR - Turchia 6
VN - Vietnam 6
FI - Finlandia 5
ID - Indonesia 4
IN - India 3
EU - Europa 2
NL - Olanda 2
CZ - Repubblica Ceca 1
IR - Iran 1
JP - Giappone 1
MX - Messico 1
MY - Malesia 1
RO - Romania 1
Totale 976
Città #
Fairfield 95
Southend 89
Ashburn 55
Chandler 54
Woodbridge 47
Dublin 46
Wilmington 40
Nyköping 37
Dearborn 36
Seattle 36
Houston 32
Jacksonville 29
Cambridge 24
Hong Kong 23
Ann Arbor 14
Beijing 12
Ottawa 12
Singapore 10
Modena 9
San Diego 8
Eugene 7
Princeton 6
Sofia 6
Falls Church 5
London 5
New York 5
Dong Ket 4
Helsinki 4
Izmir 4
Jakarta 4
San Mateo 4
Bremen 3
Guangzhou 3
Redwood City 3
Shanghai 3
Bra 2
Hanoi 2
Jinan 2
Kunming 2
Nanjing 2
San Giuliano Milanese 2
Shenyang 2
Turin 2
Boardman 1
Brno 1
Chiswick 1
Chongqing 1
Dongguan 1
Fremont 1
Fuzhou 1
Groningen 1
Los Angeles 1
Milan 1
Monmouth Junction 1
Mountain View 1
Nanchang 1
Napoli 1
Nürnberg 1
Phoenix 1
Pune 1
Rome 1
Segrate 1
Targu 1
Tehran 1
Tokyo 1
Toronto 1
Zhengzhou 1
Totale 814
Nome #
M09Quantification of circulating cell-free DNA by fluorimetry (Qubit) and spectrophotometry (NanoDrop) in patients with malignant melanoma and prostate cancer 206
Predictive role of haemoglobin on disease response to neoadjuvant chemotherapy in breast cancer. 186
Safety and efficacy of T-DM1 in HER2 positive metastatic breast cancer patients: a real word experience. 164
Quantification of circulating cell-free DNA by fluorimetry (Qubit) and spectrophotometry (NanoDrop) in patients with malignant melanoma and prostate cancer 159
Molecular profile in primary and metastatic breast cancer treated with Exemestane and Everolimus. 148
Pre and post anti Her-2 therapy era: a mono-institutional analysis of the outcome in patients with residual disease after neoadjuvant therapy for Her-2 positive locally advanced breast cancer. 122
Totale 985
Categoria #
all - tutte 3.471
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.471


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020196 27 2 4 6 25 29 37 25 15 10 12 4
2020/2021203 19 2 9 7 6 29 9 37 12 21 17 35
2021/2022154 11 34 2 4 9 17 7 12 13 10 23 12
2022/2023182 26 23 8 13 22 13 6 4 58 1 3 5
2023/202475 2 4 4 12 14 7 14 6 0 1 0 11
2024/202510 10 0 0 0 0 0 0 0 0 0 0 0
Totale 985